Friday 6 November 2026
Export TDOC’s income statement to Excel — free account
Teladoc Health, Inc.
TDOC Healthcare Health Information Services
Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024.
- Revenue
- −3.41%
- EPS
- +47.1%
- Free cash flow
- +11.8%
- Total debt
- +0.36%
Quarter to September 2026, against a year earlier
8.78
0.63
−6.70%
Follow TDOC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 5 |
+8 more TTM periods Free account |
| (11.52%) | (12.99%) | (12.39%) | (13.93%) | ||
| (5.48%) | (6.28%) | (5.48%) | (6.28%) | ||
ROIC |
(7.06%) | (7.62%) | (8.07%) | (10.27%) | |
Return on Tangible Assets |
93.78% | 85.01% | (22.71%) | (27.02%) | |
Average Days of Receivables |
34.15 | 32.40 | 31.01 | 27.82 | |
Free Cash Flow per Share |
0.69 | 0.49 | 0.87 | 0.78 | |
Free Cash Flow |
126.12 | 88.56 | 156.26 | 137.33 | |
Capital Expenditures |
(142.26) | (172.62) | (131.69) | (157.02) | |
| Other line items | |||||
Cash ROIC |
4.01% | 2.87% | 5.07% | 4.34% | |
Accounts Receivable Turnover |
11.18 | 11.15 | 11.26 | 12.43 | |
Accounts Payable Turnover |
15.74 | 16.81 | 15.88 | 19.03 | |
Inventory Turnover |
21.96 | 23.07 | 22.20 | 20.21 | |
Average Days of Payables |
21.81 | 17.71 | 21.36 | 22.69 | |
Days of Inventory on Hand |
14.47 | 13.62 | 14.91 | 18.07 | |
Tax Rate |
(0.02) | (0.03) | (0.08) | (0.15) | |
Research and Development Expense of Revenue |
10.85% | 10.84% | 10.97% | 10.99% | |
Selling, General and Administrative Expense of Revenue |
48.15% | 49.26% | 49.91% | 50.58% | |
Share Based Compensation of Revenue |
2.08% | 2.28% | 2.78% | 3.18% | |
Interest Coverage |
(8.00) | (9.36) | (10.57) | (13.34) | |
Operating CF/Net income |
(1.73) | (1.47) | (1.68) | (1.47) | |
Depreciation/Fixed assets |
15.48 | 15.82 | 14.96 | 16.62 | |
Capex/Depreciation |
(0.38) | (0.44) | (0.33) | (0.35) | |
Revenue per Share |
13.57 | 13.75 | 14.04 | 14.36 | |
Operating CF per Share |
1.48 | 1.44 | 1.61 | 1.67 | |
Capex per Share |
(0.78) | (0.95) | (0.74) | (0.89) | |
Capex to Sales |
0.06 | 0.07 | 0.05 | 0.06 |
Columns are period end dates · fundamentals updated 2 Nov 2026